Doctor profile · Federal record
Dr. Paige Lovelace, PA-C
Physician Assistant · Physician Assistant · Providence, RI
- NPI 1285038562
- Accepts Medicare
- MIPS 97.5 / 100 · 2023
- 12 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1287 N Main St
Providence, RI 029041856
(401) 272-2724
fax (401) 272-2784 - Mailing address
-
1805 Nw Platte RD Ste 120
Riverside, MO 641507500
Credentials & registration
- NPI registered
- October 2014 — 12 yrs on file
- Profile last updated
- January 23, 2020
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- Massachusetts #PA · Rhode Island #PA00923
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285038562. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,244
Distinct HCPCS
10
Medicare allowed
$112,878
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 774 | 164 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 339 | 263 | $72 | |
17000 |
Destruction of precancer skin growth, 1 growth | 314 | 238 | $40 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 307 | 227 | $103 | |
11102 |
Biopsy of related skin growth, first growth | 202 | 177 | $72 | |
17110 |
Destruction of skin growth, 1-14 growths | 152 | 125 | $89 | |
11103 |
Biopsy of related skin growth, each additional growth | 60 | 41 | $39 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 48 | 48 | $90 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 26 | 26 | $134 | |
11104 |
Punch biopsy, first skin growth | 11 | 11 | $100 |
In context: peer comparison
Among 42 peers in this city , average services per provider: 90. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$2,688
Transactions
115
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 25 | $635.34 | |
| E.R. Squibb & Sons, L.L.C. | 12 | $355.38 | |
| Janssen Biotech, Inc. | 11 | $326.25 | |
| Dermavant Sciences, Inc. | 21 | $260.70 | |
| Lilly USA, LLC | 10 | $185.74 | |
| Amgen Inc. | 8 | $171.80 | |
| Novartis Pharmaceuticals Corporation | 5 | $128.26 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $95.55 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $95.37 | |
| Organogenesis Inc. | 1 | $95.20 | |
| Almirall LLC | 3 | $91.23 | |
| UCB, Inc. | 4 | $82.65 | |
| PFIZER INC. | 3 | $62.82 | |
| Janssen Pharmaceuticals, Inc | 3 | $56.03 | |
| Incyte Corporation | 1 | $28.44 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
408
Patients
299
Total drug cost
$14,207
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 121 | 78 | $3,068 |
| Triamcinolone Acetonide | Generic | 61 | 55 | $440 |
| Fluorouracil | Generic | 59 | 52 | $4,678 |
| Clobetasol Propionate | Generic | 54 | 45 | $2,920 |
| Mupirocin | Generic | 40 | 33 | $295 |
| Hydrocortisone | Generic | 27 | 23 | $198 |
| Clindamycin Phosphate | Generic | 18 | 13 | $586 |
| Metronidazole | Generic | 17 | 0 | $1,966 |
| Spironolactone | Generic | 11 | 0 | $56 |
Frequently asked questions
What is Dr. Paige Lovelace's medical specialty?
Dr. Paige Lovelace practices Physician Assistant in Providence, RI.
Where does Dr. Paige Lovelace practice?
Dr. Paige Lovelace practices at 1287 N Main St, Providence, RI 029041856. Office phone: 4012722724.
What is Dr. Paige Lovelace's NPI?
Dr. Paige Lovelace's National Provider Identifier (NPI) is 1285038562, issued by NPPES.
Does Dr. Paige Lovelace accept Medicare assignment?
Yes. Dr. Paige Lovelace accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Paige Lovelace commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.